An2 Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $55k | 11k | 5.03 |
| 2025-03-31 | $66 | 49 | 1.37 |
| 2024-12-31 | $71 | 52 | 1.38 |
| 2024-09-30 | $58 | 54 | 1.07 |
| 2024-06-30 | $2.2k | 1.0k | 2.15 |
| 2023-03-31 | $84k | 8.5k | 9.87 |
| 2022-12-31 | $60k | 6.3k | 9.58 |
| 2022-06-30 | $19k | 2.5k | 7.66 |